Baird Financial Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.71M | Sell |
|
|||||
|
2025
Q1 | $6.39M | Buy |
|
|||||
|
2024
Q4 | $7.47M | Buy |
|
|||||
|
2024
Q3 | $3.46M | Sell |
|
|||||
|
2024
Q2 | $9.49M | Buy |
|
|||||
|
2024
Q1 | $4.44M | Buy |
|
|||||
|
2023
Q4 | $3.37M | Sell |
|
|||||
|
2023
Q3 | $2.97M | Buy |
|
|||||
|
2023
Q2 | $2.47M | Buy |
|
|||||
|
2023
Q1 | $1.27M | Sell |
|
|||||
|
2022
Q4 | $2.09M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $295K | Hold |
|
|||||
|
2021
Q3 | $332K | Hold |
|
|||||
|
2021
Q2 | $337K | Sell |
|
|||||
|
2021
Q1 | $435K | Buy |
|